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Structural basis of mitochondrial transcription initiation
Hauke S. Hillen1, Yaroslav I. Morozov2, Azadeh Sarfallah2, Dmitry Temiakov2, and Patrick 
Cramer*,1
1Max Planck Institute for Biophysical Chemistry, Department of Molecular Biology, Am Fassberg 
11, 37077 Göttingen, Germany.
2Department of Cell Biology, Rowan University, School of Osteopathic Medicine, 2 Medical Center 
Dr, Stratford, NJ 08084, USA
Summary
Transcription in human mitochondria is driven by a single-subunit, factor-dependent RNA 
polymerase (mtRNAP). Despite of its critical role in both expression and replication of the 
mitochondrial genome, transcription initiation by mtRNAP remains poorly understood. Here we 
report crystal structures of human mitochondrial transcription initiation complexes assembled on 
both light and heavy strand promoters. The structures reveal how transcription factors TFAM and 
TFB2M assist mtRNAP to achieve promoter-dependent initiation. TFAM tethers the N-terminal 
region of mtRNAP to recruit the polymerase to the promoter, whereas TFB2M induces structural 
changes in mtRNAP to enable promoter opening and trapping of the DNA non-template strand. 
Structural comparisons demonstrate that the initiation mechanism in mitochondria is distinct from 
that in the well-studied nuclear, bacterial, or bacteriophage transcription systems, but that 
similarities are found on the topological and conceptual level. These results provide a framework 
for studying the regulation of gene expression and DNA replication in mitochondria.
Introduction
Transcription of the human mitochondrial genome is carried out by the single-subunit 
mitochondrial RNA polymerase (mtRNAP), which initiates at the light strand promoter 
(LSP) and the divergent heavy strand promoter (HSP). In addition to its pivotal role in 
producing mitochondrial rRNA, tRNA and mRNA, mtRNAP also generates the RNA primer 
required for replication of the mitochondrial genome (Agaronyan et al., 2015; Gustafsson et 
al., 2016). Thus, transcription initiation is a key regulatory step for mitochondrial gene 
expression and for organelle biogenesis and maintenance.
To achieve promoter specific initiation, mtRNAP requires the mitochondrial transcription 
factor A (TFAM) and the mitochondrial transcription factor B2 (TFB2M). Previous 
biochemical studies have established that TFAM functions in promoter recruitment (Gaspari 
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et al., 2004; Morozov et al., 2014), whereas TFB2M is required for DNA opening (Gaspari 
et al., 2004; Morozov et al., 2014; 2015; Ramachandran et al., 2016). The structures of free 
mtRNAP (Ringel et al., 2011) and free TFAM (Ngo et al., 2011; Rubio-Cosials et al., 2011) 
are known, but no structures have been reported for TFB2M or the initiation complex (IC) 
containing TFAM, TFB2M and mtRNAP. Thus, it remains elusive how TFAM and TFB2M 
cooperate with mtRNAP to enable transcription initiation.
MtRNAP belongs to the pol A family of single subunit (ss) DNA-dependent RNAPs, which 
also includes the well-studied RNAP from bacteriophage T7. All ssRNAPs share high 
sequence homology in their carboxy-terminal domains (CTD) that form a fold resembling a 
right hand (Jeruzalmi and Steitz, 1998; Kohlstaedt et al., 1992). The CTD forms the catalytic 
core of these enzymes and comprises the conserved palm and the mobile fingers 
subdomains. The CTD also contains the ‘specificity loop’, a β-hairpin that binds the major 
groove of promoter DNA and forms base-specific contacts in T7 RNAP (Cheetham and 
Steitz, 1999; Gleghorn et al., 2008). Despite the conservation of the CTD, T7 RNAP does 
not require initiation factors, and accomplishes DNA binding and opening independently 
(Cheetham et al., 1999), in contrast to mtRNAP.
This functional difference results mainly from distinct amino-terminal regions of ssRNAPs 
that show very limited homology and differ in size between these enzymes. In phage 
RNAPs, the amino-terminal regions contain a promoter-binding domain (PBD) (Durniak et 
al., 2008). In T7 RNAP, the PBD forms a six-helix bundle that includes two DNA-binding 
elements, the intercalating hairpin and the AT-rich recognition loop (Cheetham et al., 1999; 
Durniak et al., 2008). The intercalating hairpin separates DNA strands during promoter 
opening and interacts with the DNA template strand (Cheetham and Steitz, 1999; Gleghorn 
et al., 2008). The AT-rich recognition loop binds the minor groove of upstream promoter 
DNA (Cheetham et al., 1999). Whereas the AT-rich recognition loop is reduced and appears 
to play no role in promoter binding, the specificity loop and intercalating hairpin of 
mtRNAP were suggested to be functional homologs of their T7 RNAP counterparts (Ringel 
et al., 2011). However, the positions observed for these elements in the apo structure of 
mtRNAP appear incompatible with promoter binding and opening, and hence the structural 
basis for mtRNAP initiation and its dependency on transcription factors remains unknown.
Here we determine crystal structures of human TFB2M and mitochondrial ICs assembled on 
light and heavy strand promoter DNA. The structures reveal the locations of transcription 
factors TFAM and TFB2M on the mtRNAP surface and suggest how they enable recruitment 
of promoter DNA to mtRNAP and DNA opening. We also provide detailed comparisons of 
the IC structure with structures of functional complexes of T7 RNAP. Our results reveal the 
distinct nature of mitochondrial transcription initiation and its molecular basis.
Results
Structure of human TFB2M
To investigate the mechanism of mitochondrial transcription initiation, we first completed 
the set of structures for the involved proteins by determining the structure of TFB2M. 
Extensive crystallization trials using full-length human TFB2M did not yield crystals. We 
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therefore designed a variant lacking apparently flexible regions that may impair 
crystallization (Methods). This variant, TFB2Mcryst, lacks 62 N-terminal residues and a 
predicted internal loop (residues 268–294) that was replaced by a short GSSG-linker. 
Functional characterization of this TFB2M variant shows that replacement of the internal 
loop does not affect the transcriptional activity (Figure S1C), whereas the N-terminal 
truncation of TFB2M reduces the activity due to its role in interactions with the priming 
nucleotide (Figure S1C) (Sologub et al., 2009). TFB2Mcryst yielded crystals that diffracted 
to 1.75 Å resolution and the structure was solved by molecular replacement (Table S1). The 
refined model shows very good stereochemistry and contains residues 72–396 of TFB2M 
with the exception of a short flexible loop (residues 91–96).
The structure (Figure 1) shows that TFB2M resembles the paralogous mitochondrial 
methyltransferase TFB1M (Guja et al., 2013) and the yeast mitochondrial transcription 
initiation factor Mtf1 (Schubot et al., 2001) (Figure S1A and B). As predicted from sequence 
homology, the N-terminal domain (residues 72–305) adopts a fold resembling S-adenosyl-
methinonine-dependent methyltransferases with a central seven-stranded β-sheet flanked on 
either side by three α-helices (Martin and McMillan, 2002). Similar to TFB1M and Mtf1, 
TFB2M deviates from the canonical methyltransferase fold by an insertion between β6 and 
β7, which corresponds to the region replaced with the GSSG linker in the crystallization 
construct (Guja et al., 2013; Schubot et al., 2001). In addition, TFB2M displays a prominent 
loop insertion between β3 and α4 not found in either of the two other proteins. The C-
terminal domain (residues 306–396) consists of four α-helices and an extended C-terminal 
tail (residues 389–396), which is likely flexible in solution because density for this region 
was only observed for one of the two copies in asymmetric unit. The structure of TFB2M 
completes the set of high-resolution structures of proteins involved in mitochondrial 
transcription initiation.
Structure determination of the mitochondrial transcription initiation complex
We then assembled a transcriptionally active IC consisting of TFAM, TFB2M, mtRNAP, and 
either LSP or HSP DNA containing a pre-melted region spanning register −4 to +3, which 
corresponds to the DNA region initially unwound around the transcription start site +1 
(Ramachandran et al., 2016) (Figure S2A and S2B). After extensive optimization, crystals of 
the IC were obtained that diffracted to 4.5 Å resolution.
The IC crystal structure was determined by a combination of molecular replacement and 
anomalous diffraction (Methods and Tables S2 and S3), which led to an interpretable 
electron density map (Figure S2E). The known structures of mtRNAP (Schwinghammer et 
al., 2013) and TFAM (Ngo et al., 2011) were fitted into the electron density and the newly 
obtained TFB2M structure could be unambiguously placed. Correct positioning of TFB2M 
was verified using an anomalous difference Fourier map that revealed selenium peaks for all 
nine methionine residues (Figure S2C). Most of the DNA could be built, except for parts of 
the single-stranded region, and the correct sequence register was confirmed using anomalous 
diffraction from 5-Bromo-Uracil labelled DNA scaffolds (Figure S2D and Table S3). This 
led to an atomic model for the IC refined to a free R-factor of 31 % (Table S2). We also 
solved a 4.5 Å resolution crystal structure of the IC assembled on the HSP promoter (Table 
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S4). This structure was essentially identical to the LSP IC (r.m.s.d. = 0.23 Å over 10,136 
atoms) (Figure S2F) and in the following we focus our discussion on the LSP IC.
IC structure reveals locations of TFAM, TFB2M, and DNA on mtRNAP
The IC structure (Figure 2B) reveals that mtRNAP is largely unchanged compared to the 
previously reported EC structure (Schwinghammer et al., 2013), with the exception of the 
fingers domain, which adopts the ‘clenched’ conformation observed in the apo enzyme 
(Ringel et al., 2011). Whereas the position of the downstream DNA duplex in the IC is 
identical to that observed in the EC, the upstream DNA occupies a different location, 
running along the NTD of mtRNAP. The conserved intercalating hairpin of mtRNAP 
separates the DNA strands at the upstream edge of the open DNA region observed in the 
active center cleft of the polymerase (Figure 2B and 3A).
TFB2M contacts the intercalating hairpin and covers the junction between the upstream 
DNA duplex and the open DNA region (Figure 2B and 3A). TFAM binds DNA 16–39 nt 
upstream of the transcription start site and induces a ~180° bend into DNA, resembling the 
free TFAM-DNA complex (Ngo et al., 2011; Rubio-Cosials et al., 2011). In agreement with 
cross-linking data (Morozov et al., 2014), TFAM does not contact TFB2M, but binds the N-
terminal domain (NTD) of mtRNAP at helix D. In addition to the severe upstream bend in 
the DNA induced by TFAM binding, the trajectory of the DNA is changed by ~45° between 
mtRNAP and TFAM (Figure 3B). This is apparently caused by interactions of the PPR 
domain with the DNA backbone at register −10 to −15 (Figure 3B and C), where the DNA 
minor groove appears widened. In addition, the downstream DNA in the IC duplex encloses 
an angle of ~135° relative to the upstream duplex at the point of DNA melting (Figure 3B).
TFAM recruits mtRNAP to promoter DNA
The IC structure explains how TFAM recruits mtRNAP to promoter DNA (Gaspari et al., 
2004; Morozov et al., 2014; Posse et al., 2014). The HMG Box B domain of TFAM interacts 
with a newly observed ‘tether’ helix in the N-terminal extension of mtRNAP, thereby 
anchoring mtRNAP to the promoter (Figure 4, S3A and Movie S1). The C-terminal tail of 
TFAM is located close to the PPR domain and residues 444–462 of mtRNAP (D-helix), 
consistent with published biochemical, genetic and cross-linking data (Dairaghi et al., 
1995a; Morozov and Temiakov, 2016; Morozov et al., 2015) (Figure 4). These contacts 
enable TFAM to recruit mtRNAP and position its active site over the transcription start site 
for de novo RNA synthesis (Dairaghi et al., 1995b; Morozov et al., 2014). In agreement with 
cross-linking data (Morozov and Temiakov, 2016), TFAM binding is identical in the 
structure of the HSP IC (Figure S3B). There, similarly to the LSP IC, TFAM binds to the 
region that is located 16–39 bp upstream to the HSP transcription start site, in agreement 
with footprinting data (Fisher et al., 1987). This indicates that the two transcription units in 
human mitochondria possess similar architecture, in contrast to previous reports that 
suggested no role of the TFAM C-terminal tail in LSP activation (Uchida et al., 2017) and 
proposed opposite orientations of TFAM relative to mtRNAP in the IC assembled on HSP 
DNA (Ngo et al., 2014).
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TFB2M assists mtRNAP in DNA opening
The IC structure also reveals how TFB2M assists mtRNAP in promoter opening and 
stabilization of open DNA (Morozov et al., 2015; Posse and Gustafsson, 2016; 
Ramachandran et al., 2016). First, TFB2M binds the duplex DNA around base −7 with its 
conserved arginine residues R330 and R331 (Figure 5A, 5C and Figure S4A and B). 
Mutation of these residues to alanine severely impairs transcription initiation (Figure 5D). 
Second, TFB2M induces conformational changes in mtRNAP that stabilize open DNA. 
Comparison of the IC and the apo mtRNAP structure indicates that TFB2M binding induces 
a rotation of the PBD of mtRNAP (residues 420–520 and 557–637), which includes the 
intercalating hairpin. This rotation moves the intercalating hairpin by ~7 Å and positions it 
between DNA strands (Figure 5A and Movie S1). The intercalating hairpin is further 
buttressed by TFB2M helix α8, which contains residues that are essential for activity 
(Morozov et al., 2015), including residue H326, which is critical for transcription initiation 
(Figure 5A and 5D and Figure S4A).
The PBD also harbours a ‘lever’ loop (residues 588–604), a structural element that is located 
adjacent to the intercalating hairpin and found in mtRNAP but not in phage RNAPs. The 
lever loop is essential for initiation (Morozov et al., 2015) and likely plays a key role in 
TFB2M-induced rotation of the core NTD. The lever loop would clash with bound TFB2M 
if it adopted the position observed in free mtRNAP (Figure 5A). In the IC, the lever loop 
interacts with loop α9-α10 in TFB2M (residues 341–347), and this may stabilize the rotated 
NTD core. Indeed, mutation of an arginine residue in the lever loop (R601E) results in 
decreased transcription initiation (Figure 5D). Comparison with the structure of free TFB2M 
reveals that the C-terminal tail of TFB2M (residues 389–396) has apparently moved to 
accommodate the intercalating hairpin of mtRNAP in the position observed in the IC (Figure 
S4A). The C-terminus of TFB2M appears to stabilize the intercalating hairpin, as its 
shortening by eight amino acids leads to a reduction in activity (Figure 5D).
Finally, TFB2M traps the non-template DNA strand in the open DNA region. This was 
previously suggested for Mtf1 (Paratkar and Patel, 2010) and is reminiscent, on the 
topological level, of the bacterial initiation factor sigma (Feklistov and Darst, 2011; 
Helmann and Chamberlin, 1988; Zhang et al., 2012). The NTD of TFB2M displays a 
positively charged surface that guides the DNA non-template strand away from the template 
strand (Figure 5B). Three conserved positively charged residues (R198, K201 and K202) 
protrude from loop β4-α5 and helix α5 of TFB2M towards the non-template strand and are 
required for efficient initiation (Figure 5A, 5C and S4A). Further DNA interactions may be 
formed by the positively charged residues K153, R157, K163 and K206, which line the 
projected path of the non-template strand, and residues K325, K232 and K236 close to the 
duplex DNA (Figure 5C). Most of these positively charged residues are conserved in 
TFB2M from human and mouse, arguing for their functional importance. Consistent with 
this, these residues are not strongly conserved in the paralog TFB1M, which is not involved 
in transcription initiation (Figure S4B) (Litonin et al., 2010; Metodiev et al., 2009).
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Comparison to T7 RNAP initiation
Comparison of the mitochondrial IC structure to the structure of the T7 RNAP IC 
(Cheetham et al., 1999) reveals possible reasons for the requirement of initiation factors by 
mtRNAP. Promoter recognition by T7 RNAP is achieved in part through sequence-specific 
DNA contacts at registers −5 to −11 formed by the specificity loop (Figure 6A and Figure 
S5). The specificity loop in mtRNAP shows only fragmented density in the DNA major 
groove around registers −9 to −7, arguing against a prominent role of this loop in promoter 
recognition. Consistent with this, LSP and HSP share no sequence homology in this region 
and DNA base mutations hardly change initiation activity (Gaspari et al., 2004). In addition 
to the specificity loop, T7 RNAP engages with promoter DNA via the AT-rich recognition 
loop, which inserts into the upstream DNA minor groove between registers −17 and −13 
(Cheetham et al., 1999). (Figure 6A). The structure of the IC demonstrates that mtRNAP 
does not form sequence-specific contacts with promoter DNA in this region. Instead, only 
interactions between the PPR domain of mtRNAP and the upstream DNA backbone were 
detected (Figure 3A and C). Thus, recruitment of mtRNAP to DNA-bound TFAM 
apparently substitutes for the lack of extensive DNA interactions formed by T7 RNAP with 
promoter DNA.
Opening of the DNA duplex by T7 RNAP is facilitated by the intercalating hairpin, which 
separates the two DNA strands at the upstream edge of the DNA bubble. In the apo mtRNAP 
structure, the intercalating hairpin has been observed in a conformation that is incompatible 
with promoter melting (Ringel et al., 2011). In the mitochondrial IC, however, the 
intercalating hairpin and specificity loop are arranged as in the T7 RNAP IC (Figure S5). 
This suggests that binding of TFB2M stabilizes an initiation-competent conformation of 
mtRNAP that is characterized by properly positioned elements required for DNA opening, 
including the intercalating hairpin (Figure 6A and Figure S5). In summary, comparison of 
the mitochondrial IC and the T7 RNAP IC suggests that TFAM compensates for the lack of 
prominent RNAP-promoter interactions upstream of the point of DNA opening and that 
TFB2M assists in promoter opening by positioning key structural elements in mtRNAP in a 
fashion reminiscent of T7 RNAP.
Transition from initiation to elongation
After RNA chain initiation, mtRNAP must lose its interactions with TFAM and TFB2M in 
order to transition to the elongation phase. In the case of T7 RNAP, this initiation-elongation 
transition is accompanied by substantial refolding of the polymerase, which destroys the 
PBD (Tahirov et al., 2002; Yin and Steitz, 2002). In contrast, comparison of the 
mitochondrial IC with the EC structure (Schwinghammer et al., 2013) demonstrates that the 
mtRNAP conformation remains largely unchanged. Instead, the DNA rearranges during the 
initiation-elongation transition. In the EC, upstream DNA is repositioned and occupies the 
binding site of TFB2M, which must therefore dissociate during the transition (Figure 6B). 
TFB2M dissociation is also required for binding of the elongation factor TEFM (Figure 6B), 
which also interacts with the intercalating hairpin of mtRNAP and critically affects 
processivity of the elongation complex (EC) (Hillen et al., 2017). The transition further 
creates a channel for RNA exit underneath the intercalating hairpin, which remains in an 
open conformation and now separates the exiting RNA from the DNA template 
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(Schwinghammer et al., 2013). Thus, TFB2M positions the intercalating hairpin for 
initiation, and this position of the hairpin is largely maintained during subsequent 
elongation. These comparisons highlight the dramatic differences between mtRNAP and T7 
RNAP with respect to the structural changes that occur during the initiation-elongation 
transition when the polymerase escapes from the promoter.
Discussion
In this study we extend our previous structural work on mitochondrial transcription from 
elongation (Schwinghammer et al., 2013) to initiation. Our structures of the ICs demonstrate 
the conserved architecture of the transcription complexes that assemble at divergent human 
mitochondrial promoters and support the sequential model of transcription initiation 
(Morozov et al., 2014) (Figure 7 and Movie S1). First, recruitment of mtRNAP to TFAM-
bound promoter DNA positions mtRNAP at the transcription start site. This explains the 
critical role of the distance between the TFAM-binding site and the start site in initiation 
(Dairaghi et al., 1995b). Subsequent binding of TFB2M induces DNA opening and stabilizes 
open DNA with the use of conformational changes and binding energy. TFB2M positions 
the intercalating hairpin of the polymerase for DNA opening. Initial RNA synthesis may 
then be facilitated by the N-terminal region of TFB2M (residues 21–71), which is mobile in 
the IC structure but can be cross-linked to the priming nucleotide (Sologub et al., 2009).
The transition from initiation to elongation is accompanied by a dramatic rearrangement of 
the upstream DNA, as observed for the related T7 RNAP (Yin and Steitz, 2002). However, 
in contrast to T7 RNAP (Yin and Steitz, 2002), the conformation of mtRNAP remains 
largely unchanged during the transition. Instead, the transition involves dissociation of the 
initiation factors. Comparison of the IC structures with our recent structure of the EC bound 
by the mitochondrial elongation factor TEFM (Hillen et al., 2017) demonstrates that TFB2M 
and TEFM binding to mtRNAP are mutually exclusive. Thus, TFB2M must be released 
before TEFM can bind mtRNAP. These results indicate changes that occur during the 
initiation-elongation transition of mitochondrial transcription.
Our structural data also show how the initiation mechanism of mtRNAP differs from that 
used by multisubunit RNAPs. Like mtRNAP, multisubunit RNAPs depend on additional 
factors for initiation, but these factors are not homologous to TFAM and TFB2M, neither on 
the sequence level nor at the structural level. There are, however, conceptual similarities 
between all initiation systems. In particular, TFB2M traps the non-template strand in the 
open DNA region, in a manner that is topologically similar to the sigma factor required by 
bacterial RNAP for initiation (Feklistov and Darst, 2011; Murakami and Darst, 2003; Zhang 
et al., 2012). The eukaryotic RNA polymerase I initiation machinery apparently also uses 
trapping of the open DNA (Engel et al., 2017; Han et al., 2017; Sadian et al., 2017).
In conclusion, our results provide the structural basis of mitochondrial transcription 
initiation and suggest structural rearrangements that occur during the transition to 
transcription elongation. The mitochondrial initiation system employs mechanisms of 
initiation that are clearly distinct from those observed for nuclear, bacterial or bacteriophage 
RNAPs. This likely reflects the need for regulating mitochondrial transcription, which is not 
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only required for the expression of essential genes and the synthesis of ribosomal and 
transfer RNA, but also to generate RNA primers for replication of the mitochondrial genome 
(Agaronyan et al., 2015; Gustafsson et al., 2016).
STAR METHODS
Contact for reagent and resource sharing
Further information and requests for resources and reagents should be directed to and will be 
fulfilled by the Lead Contact Patrick Cramer (patrick.cramer@mpibpc.mpg.de)
Experimental model and subject details
For cloning we used the Escherichia coli strain XL1-Blue (Agilent) and for recombinant 
expression the Escherichia coli strains BL21CodonPlus (DE3) RIL (Agilent) and Rosetta2 
(DE3) pLysS (Merck Millipore). Cells were grown at 37°C as described in the STAR 
Methods Details section.
Method Details
Protein expression constructs—A construct of human mtRNAP lacking the N-
terminal 104 amino acids (Δ104mtRNAP, E555A natural variant) with an N-terminal 6-His 
tag and a TEV cleavage site was constructed from the pProEx-based expression plasmid 
described previously (Sologub et al., 2009). Human TFAM was expressed as a construct 
lacking the mitochondrial localization sequence (res. 1–42) and two cysteine residues (C49S 
and without the C-terminal C246), mutations which have been shown to have no effect on 
activity (Morozov et al., 2014). The construct was cloned from the previously described 
pET22b-based expression plasmid (Morozov et al., 2014) by inserting a TEV cleavage site 
between the N-terminal 6-His tag and the coding. Human TFB2M was expressed as a 
construct lacking either only the predicted mitochondrial localization sequence (res. 1–20; 
Δ20TFB2M) or lacking the N-terminal 62 residues (Δ62TFB2M). The construct was 
generated from the pTYB11-based expression vector described previously (Sologub et al., 
2009) by removing the intein tag and replacing it with a TEV-cleavable N-terminal 6-His 
tag.
To obtain a crystallizable variant of human TFB2M, we used limited proteolysis combined 
with Edman sequencing to map regions sensitive to proteolysis. This approach identified two 
regions sensitive to cleavage by Trypsin (around residues K63 and R288), indicating 
potentially less ordered regions of the protein. We then used secondary structure prediction 
(PSIPRED) (Buchan et al., 2013) together with a computationally generated 3D homology 
model (Swiss Model) (Biasini et al., 2014), which we compared to S.cerevisiae Mtf1 (PDB 
ID 1I4W) (Schubot et al., 2001) and M.musculus TFB1M (PDB ID 4GC5) (Guja et al., 
2013), to delineate the boundaries of the putative flexible regions. This approach led us to 
design the crystallization variant, TFB2Mcryst, which lacks 62 amino acids at the N-terminus 
and a loop region between residues 268 and 294, for which no electron density could be 
observed in the IC and which was replaced by a short GSSG linker. Expression plasmids for 
structure determination were generated by round the horn PCR. All TFB2M variants used in 
transcription assays were generated using QuickChange Mutagenesis kit (Agilent) in N-his 
Hillen et al. Page 8
Cell. Author manuscript; available in PMC 2019 June 24.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Δ20TFB2M background. The R601E mtRNAP variant was generated using Δ119mtRNAP 
background.
Protein expression and purification—Human mtRNAP was expressed in E.coli BL21 
(DE3) RIL cells (Agilent) and purified essentially as described previously (Sologub et al., 
2009). Briefly, cells were grown until the OD600 reached 0.6 units and expression was 
induced by addition of 0.15 mM IPTG and carried out at 16 °C for 18 h. MtRNAP was 
purified by affinity chromatography using Ni-NTA beads (Qiagen) followed by tag cleavage 
using TEV protease. The protein was further purified by Heparin affinity chromatography 
using a HiTrap Heparin HP column (GE Healthcare) followed by size exclusion 
chromatography using a Superdex 200 Increase 10/300 column (GE Healthcare) equilibrated 
with mtRNAP Buffer (40 mM Tris/HCl pH 8.0, 300 mM NaCl, 20 mM MgCl2, 5% 
Glycerol, 10 mM DTT). Peak fractions were pooled, concentrated and stored at −80 °C.
Human TFAM was expressed in E.coli BL21 Rosetta2 pLysS cells (Merck Millipore). Cells 
were grown until the OD600 reached 1.0 units and expression was induced by addition of 0.8 
mM IPTG and carried out at 37 °C for 1.5 h. TFAM was purified by affinity chromatography 
using a HisTrap HP 5 ml column (GE Healthcare) followed by tag cleavage using TEV 
protease and reverse Ni-NTA affinity chromatography. The protein was further purified by 
ion exchange chromatography using a HiTrap SP HP column (GE Healthcare) followed by 
Heparin affinity chromatography using a HiTrap Heparin HP column (GE Healthcare). Final 
purification was done by size exclusion chromatography using a HiPrep 16/600 Superdex 75 
pg column (GE Healthcare) equilibrated with TFAM buffer (40 mM Tris/HCl pH 8.0, 100 
mM NaCl, 5% Glycerol, 10 mM DTT). Peak fractions were pooled, concentrated and stored 
at −80°C.
Human TFB2M was expressed in E.coli BL21 (DE3) RIL cells (Agilent). Cells were grown 
in expression media (10 g/l Tryptone, 5 g/l Yeast extract, 50 mM KH2PO4, 50 mM 
Na2HPO4, 25 mM (NH4)2SO4, 2 mM MgSO4, 0.5 % (v/v) glycerol, 0.05 % (w/v) D-
glucose) until the OD600 reached 6.0 units. Expression was induced by addition of 0.1 mM 
IPTG and carried out at 16°C for 18 h. TFB2M was purified by affinity chromatography 
using Ni-NTA beads (Qiagen) followed by tag cleavage using TEV protease and reverse Ni-
NTA affinity chromatography using a HisTrap HP 5 ml column (GE Healthcare). The 
protein was further purified by Heparin affinity chromatography using a HiTrap Heparin HP 
column (GE Healthcare) and size exclusion chromatography using a Superdex 200 Increase 
10/300 column (GE Healthcare) equilibrated with TFB2M buffer (40 mM Tris/HCl pH 8.0, 
100 mM NaCl, 5% Glycerol, 10 mM DTT). Peak fractions were pooled, concentrated and 
stored at −80°C.
For expression of selenomethionine-labeled protein, expression cultures were grown in 
SeMet Base media (Molecular Dimensions) with the addition of L-Selenomethionine (50 μg/
ml), L-Lysine (50 μg/ml), L-Threonine (50 μg/ml), L-Phenylalanine (50 μg/ml), L-Leucine 
(25 μg/ml), L-Isoleucine (25 μg/ml) and L-Valine (25 μg/ml). Selenomethionine-labeled 
protein was purified as described above.
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Crystallization of TFB2M—Crystals of TFB2M could only be obtained using a truncated 
variant of the protein, TFB2Mcryst (see above for details). TFB2Mcryst was crystallized by 
the hanging drop vapour diffusion method at 20 °C by mixing 1.5 μl of protein solution (13 
mg/ml) with 1.5 μl of reservoir solution containing 100 mM HEPES pH 7.5, 200 mM NaCl, 
17% PEG3350 and 0.4 μl of seeding solution produced from previously grown crystals in a 
similar condition. Crystals were cryo-protected by gradually increasing the Glycerol 
concentration in the drop to 25% (v/v) final and flash frozen in liquid nitrogen.
Reconstitution and crystallization of the IC—HPLC-purified synthetic DNA 
oligonucleotides were obtained from IDT. Scaffolds for crystallization were annealed by 
heating complimentary oligonucleotides (LSP IC: HH NT2 / HH TS1; HSP IC: HH NT6 / 
HH TS3; LSP Bromine 1: HH NT2 / HH TS1-Br1; LSP Bromine 2: HH NT2-Br2 / HH 
TS50; LSP Bromine 3: HH NT2 / HH TS1-Br3; LSP Bromine 4: HH NT2-Br4 / HH TS1; 
LSP Bromine 5: HH NT2 / HH TS1-Br5; LSP Bromine 6: HH NT67 / HH TS1-Br6) (Table 
S5) to 95°C and step-wise cooling to 4°C (1°/90s) at a final concentration of 0.5 mM in 
H2O.
The human IC was reconstituted by incubating Δ104 mtRNAP (35 μM) with a 1.1-fold 
molar excess of scaffold DNA, equimolar amounts of TFAM (43–245 C49S) and a 1.5-fold 
molar excess of Δ20TFB2M in a buffer containing 30 mM Tris/HCl pH 8.0, 200 mM NaCl, 
10 mM MgCl2, 5% glycerol and 10 mM DTT for 20 min at 20°C. The complex was 
subsequently purified by size exclusion chromatography using a Superdex 200 Increase 
3.2/300 column equilibrated with complex crystallization buffer (10 mM Tris/HCl pH 8.0, 
100 mM NaCl, 20 mM MgCl2, 10 mM DTT, 1 mM TCEP). Crystals were obtained by the 
hanging drop vapour diffusion method at 20 °C by mixing equal volumes of protein solution 
and reservoir solution containing 100 mM BIS-TRIS pH 6.0, 200 mM L-Proline and 5–7% 
PEG8000. Crystals were cryo-protected by gradually increasing the glycerol concentration 
in the drop to a final of 25% (v/v) and flash-frozen in liquid nitrogen. For selenomethionine 
labelling and subsequent crystallization, a construct of mtRNAP lacking the N-terminal 108 
amino acids (Δ108mtRNAP) and Δ62TFB2M were used.
Data collection, structure determination and refinement—Diffraction data were 
collected at beamline X06SA and X10SA at the Swiss Light Source in Villigen, Switzerland, 
with an EIGER 16M detector (Dectris) or a PILATUS 6M detector (Dectris), respectively, 
and at beamline P14 operated by EMBL Hamburg at the PETRA III storage ring (DESY 
Hamburg, Germany) with a Pilatus 6M detector (Dectris). The data was processed using 
XDS (Kabsch, 2010) and scaled with XSCALE (Kabsch, 2010). For selenomethionine and 
5-Bromo-Uracil containing crystals, multiple datasets (from a single crystal or multiple 
isomorphous crystals) were merged using XSCALE to improve the anomalous signal.
The crystals of TFB2Mcryst belonged to space group P21 and diffracted to a resolution of 
1.75 Å with two copies of the protein in the asymmetric unit. The structure of TFB2Mcryst 
was solved by molecular replacement in Phaser (McCoy et al., 2007) using a partial model 
of the yeast homolog Mtf1 (PDB ID 1I4W, residues 134–138; 143–198; 242–281) truncated 
to poly-alanine. Density modification and building of an initial model was done using 
phenix.autobuild (Adams et al., 2010) and subsequently completed manually in Coot 
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(Emsley et al., 2010). The model was subjected to iterative cycles of refinement in 
phenix.refine (Adams et al., 2010) and manual model building in Coot until excellent 
stereochemistry and a free R-factor of 21.4 % was obtained (Table S1). The final model 
contains residues 72–94, 97–267 and 295–396 of the wild-type TFB2M.
The IC crystals belonged to space group P21, contained two copies of the complex in the 
asymmetric unit, and showed diffraction to 4.5 Å resolution. Initial phases were obtained by 
molecular replacement using Phaser (McCoy et al., 2007) in the PHENIX suite (Adams et 
al., 2010) and the human mitochondrial transcription EC (PDB ID 4BOC) lacking nucleic 
acid as search model. The solution was subsequently used as starting phases for molecular 
replacement combined with single-wavelength anomalous diffraction (MR-SAD) and 
automated density modification in PHENIX using diffraction data collected from crystals 
containing selenomethionine-labeled mtRNAP, TFAM and TFB2M and LSP DNA. (Table 
S2) The resulting electron density map showed clear features of nucleic acids and proteins in 
addition to the search model used and was phase extended using the higher resolution native 
dataset in phenix.autobuild. Interpretation of the electron density was facilitated by 
anomalous scattering from selenium and bromine atoms incorporated into proteins and 
DNA, respectively (Figure S2C, S2D and Table S2 and S3). Anomalous difference Fourier 
maps were computed as log-likelihood gradient maps in Phaser (within the PHENIX suite) 
using phases derived from the refined IC model (Read and McCoy, 2011). Modelling of the 
IC was done largely using the experimental map and cross-validated with a map generated 
by MR-SAD with the keyword “phaser_sites_then_phase=True” to obtain a map free of 
model bias. As one molecule in the asymmetric showed better overall density than the other, 
model building and analysis was done largely based on the density for this molecule (chains 
A, C, D, E and F in the final PDB file).
Starting from the model of the EC placed by molecular replacement, individual domains and 
secondary structure elements of mtRNAP were rigid body fitted in real space manually to fit 
the experimental electron density. The tip of the thumb domain did not show convincing 
density and was therefore removed (residues 740–760). The region of mtRNAP 
corresponding to the specificity loop (residues 1086–1107) showed fragmented density and 
was modelled based on the structure of the T7 RNAP initiation complex.(Cheetham et al., 
1999) The density allowed for modelling the main chain trace of this element lacking only 
three residues (1094–1096) at the tip, yet the sequence register could not be assigned 
unambiguously and it was therefore modelled as poly-alanine (residues 1068–1107).
To obtain an initial model of the IC, the crystal structure of TFAM (Ngo et al., 2011) (PDB 
ID 3TMM) in complex with LSP DNA was fitted into the electron density and the individual 
domains were rigid body fitted locally in real space using Coot (Emsley et al., 2010). The 
DNA emerging from TFAM was extended and adjusted as ideal B-DNA to the expected 
melting point at the beginning of the mismatched region (−4) and rigid body fit locally in 
real space. The experimental density allowed for modelling of two additional bases of the 
template and three of the non-template strand, respectively, past the melting point. Although 
the density clearly showed the trajectory of the phosphate backbone, the conformation of the 
bases could not be confidently determined at this resolution and was thus modelled based on 
anomalous peaks from bromine labeled scaffolds with the help of anomalous difference 
Hillen et al. Page 11
Cell. Author manuscript; available in PMC 2019 June 24.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
peaks from crystals containing DNA labelled with 5-bromo-uracile at specific sites (Figure 
S2D). The downstream duplex DNA showed weaker density and was similarly positioned 
with the help of anomalous difference peaks (Figure S2D). In the crystal form observed, the 
downstream DNA mediates a crystal contact and may therefore be stabilized in the observed 
conformation.
To model TFB2M, the crystal structure of TFB2Mcryst was rigid body fit into the 
experimental IC density. Correct positioning of TFB2M was verified using peaks in an 
anomalous difference Fourier map calculated from the dataset, which was used for phasing 
the IC, which included selenomethionine-labelled TFB2M (Figure S2C). Placement of 
TFB2M led to a single clash between the C-terminal tail of TFB2M with the mtRNAP 
intercalating hairpin and the non-template DNA (Figure S4A). Since this C-terminal region 
appears to be flexible, the TFB2M model was truncated to the last residue with clear density 
in the IC map (residue 392).
After positioning of all known protein structures, a residual unexplained density in the 
experimental map remained close to the HMG box B of TFAM with three weak peaks in the 
anomalous difference map for selenium. An anomalous difference map calculated from a 
dataset obtained from crystals in which only mtRNAP was selenomethionine-labeled 
indicated that these peaks originate from residues within the polymerase. Based on a unique 
‘MRM’ sequence motif found in the thus far not observed N-terminal extension region of 
mtRNAP and secondary structure prediction using PSIPRED (Buchan et al., 2013), a helix 
spanning residues 122–146 in mtRNAP was assigned to the unmodeled density, which we 
termed ‘tether helix’. (Figure S3A).
Refinement of the IC model against the native dataset using phenix.refine with secondary 
structure restraints, reference model restraints and DNA geometry restraints resulted in a 
model with good geometry and a free R-factor of 31.0 %. (Table S2) The resulting mFo-DFc 
map showed difference density for some additional features such as the polypeptide path 
connecting the mtRNAP tether helix to the PPR domain, which may run along the C-
terminal end of TFAM α8, two additional helices of the PPR domain, the missing single-
stranded non-template DNA strand, and the loop in TFB2M which was deleted in the 
TFB2Mcryst variant (residues 268–294) and seems to be positioned close to the N-terminus 
of TFB2M and the downstream DNA duplex in the IC. However, we refrained from 
modelling these features due to the limited resolution of the data. Residues 235–237 at the 
C-terminal tail of TFAM did not show good density and were therefore removed from the 
model.
The structure of the HSP IC was solved by molecular replacement using the LSP IC as 
search model and subsequently adjusted to the HSP sequence. The model was refined in 
phenix.refine using a similar protocol as for the LSP IC and led to a final model with good 
stereochemistry and a free R of 33.5 %. (Table S4) The identical orientation of TFAM on 
both LSP and HSP was verified by comparing anomalous difference peaks calculated using 
structure factors from crystals containing selenomethionine-labeled TFAM and the 
respective promoter DNA. (Figure S3B)
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Figures were prepared using PyMol. Surface charge analysis was performed using the APBS 
plugin for PyMol (Baker et al., 2001) and displayed with +/− 1kT/e. Figures were prepared 
using the LSP IC model, unless stated otherwise.
Transcription assays—Standard transcription reactions were carried out using PCR-
amplified DNA templates containing the LSP promoter (region −60 to +20) as described 
previously (Morozov et al., 2015). The reactions contained DNA templates (50 nM), Δ119 
mtRNAP (50 nM), Cys-less TFAM (50 nM), Δ20 TFB2M (50 nM) in a transcription buffer 
containing 40 mM Tris (pH=7.9), 10 mM MgCl2 and 10 mM DTT in the presence of ATP 
(0.3 mM), GTP (0.3 mM), UTP (0.01 mM) and 0.3 μCi [γ−32P] UTP (800 Ci/mmol). To 
assay the activity of the IC assembled on pre-melted LSP, the reaction was performed in the 
presence of ATP (0.3 mM), GTP (0.3 mM) and 0.3 μCi [γ−32P] ATP (800 Ci/mmol) to 
generate 4–5 nt RNA products. Reactions were carried out at 35°C for 30 min and stopped 
by addition of an equal volume of 95% formamide/0.05 M EDTA. The products were 
resolved by 20% PAGE containing 6 M urea and visualized by PhosphorImager (GE 
Healthcare).
Quantification and Statistical analysis
Data for transcription initiation assays are mean values of at least three technical replicates.
Data and Software availability
Coordinate and structure factor files for the LSP and HSP IC crystal structures and for the 
human TFB2M crystal structure were deposited with the Protein Data Bank with accession 
codes 6ERP, 6ERQ and 6ERO, respectively.
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Refer to Web version on PubMed Central for supplementary material.
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Figure 1 |. Structure of human TFB2M.
(A) Schematic representation of TFB2M. The N-terminal domain is colored in marine blue, 
the C-terminal domain in slate and the C-terminal tail in orange. Regions visible in the 
electron density of the TFB2Mcryst crystals are indicated by a solid black line. The dashed 
black line represents the internal loop region replaced by a GSSG-linker in order to obtain a 
crystallizable construct.
(B) Ribbon representation of the human TFB2M structure. Coloring as in (A) with 
secondary structure elements indicated.
See also Figure S1.
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Figure 2 |. Structure of the human mitochondrial transcription initiation complex.
(A) Schematic representation of mtRNAP, TFAM and TFB2M. Important structural 
elements are indicated with flanking residue numbers. Regions with interpretable electron 
density in the IC crystal structure are indicated by a solid black line. Regions with density of 
insufficient quality for model building are indicated by a dashed black line. The colour code 
is used throughout.
(B) Ribbon representation of the IC structure assembled on LSP DNA. Important structural 
elements are indicated.
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See also Figure S2.
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Figure 3 |. Promoter DNA interactions in the IC and DNA bending.
(A) Schematic representation of protein-DNA interactions in the IC. DNA bases of the LSP 
promoter scaffold used for crystallization are depicted as circles in blue and cyan for the 
template and non-template strand, respectively. DNA bases lacking density in the IC crystal 
structure are depicted as hollow circles. Protein regions interacting with the DNA are 
indicated with coloring as in Figure 2.
(B) DNA bending observed in the IC structure. Ribbon representation of the IC LSP 
structure with mtRNAP and TFAM in the background and DNA in the foreground. Helices 
are depicted as cylinders. TFB2M was omitted for clarity. Approximate angles between 
DNA duplexes are indicated.
(C) Close-up view of the interaction between the PPR domain of mtRNAP and the upstream 
DNA duplex between the −10 and −15 bases. Several potentially interacting residues in the 
PPR domain are located close to the DNA backbone. In addition to two regions in the PPR 
domain (residues 220–222 and 252–255), R454 from the N-terminal domain of mtRNAP is 
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located in proximity to the DNA. Note that the trajectories of sidechains shown are derived 
from the high-resolution structure of the EC used for molecular replacement (PDB ID 
4BOC) (Schwinghammer et al., 2013).
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Figure 4 |. TFAM recruits mtRNAP to promoter DNA.
Close-up view of the interaction between mtRNAP and TFAM in the IC. Coloring as in 
Figure 2. Residues in TFAM and the region in mtRNAP previously shown to be functionally 
important for initiation or identified as crosslinking-points are shown in magenta (Morozov 
et al., 2014; 2015). The putative trajectory of the polypeptide connecting the tether helix to 
the PPR is indicated as a dashed line.
See also Figure S3 and Movie S1.
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Figure 5 |. TFB2M stabilizes open DNA and traps the non-template strand.
(A) TFB2M binding induces structural rearrangements in mtRNAP. Ribbon representation 
of DNA, mtRNAP and TFB2M around the point of DNA melting in the IC. Helices are 
depicted as cylinders. Functionally important residues in TFB2M are shown as sticks. The 
palm domain (residues 646–1230) of free mtRNAP (Ringel et al., 2011) (PDB ID 3SPA; 
transparent pale green) was superimposed on the IC. For clarity, only residues 420–520 and 
557–637 of mtRNAP are shown. Grey and green dashed lines indicate the trajectory of 
unresolved parts of the mtRNAP lever loop in the IC and apo mtRNAP structures, 
respectively. Arrows indicate the movement induced by TFB2M binding.
(B) Nucleic acid binding by TFB2M. The surface of TFB2M is coloured according to 
electrostatic potential with positive and negative potential in blue and red, respectively. DNA 
is shown in cartoon view. Upstream DNA and mtRNAP were omitted for clarity.
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(C) Charged residues in TFB2M in proximity to nucleic acid in the IC. TFB2M is shown as 
ribbon representation in marine blue. DNA is shown in cartoon view with coloring as in (B). 
Arginine and Lysine residues in the vicinity of the DNA are shown as sticks. Residues 
conserved as basic (R,K) in human and mouse TFB2M, but not in TFB1M, are shown in 
yellow. Residues conserved as basic in both TFB2M and TFB1M are shown in red.
(D) Activity of structure-based point mutants of mtRNAP and TFB2M in transcription 
assays.
See also Figure S4 and Movie S1.
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Figure 6 |. Comparison to T7 RNAP initiation and transition to elongation.
(A) (Left) Ribbon depiction of the LSP IC. MtRNAP is shown in grey with the intercalating 
hairpin in purple and the specificity loop in yelloworange. (Right) Ribbon depiction of the 
T7 RNAP initiation complex (PDB ID 1CEZ) (Cheetham et al., 1999). Coloring as for the 
mitochondrial IC, with the AT-rich recognition loop in red. The topology around the point of 
DNA melting is similar in both complexes. See also Figure S5.
(B) (Left) Structure of the LSP IC. TFAM and mtRNAP are depicted transparently for 
clarity. The movement of the upstream DNA upon transition to the EC is indicated with an 
arrow. (Right) Structure of the human mitochondrial transcription elongation complex with 
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the elongation factor TEFM bound (PDB ID 5OLA) (Hillen et al., 2017).MtRNAP is 
depicted transparently for clarity. The position of the downstream DNA duplex is identical in 
both the IC and the EC. The TFB2M binding site on mtRNAP is occupied by the upstream 
DNA and TEFM in the EC, demonstrating that a pronounced rearrangement of the upstream 
DNA must take place during the transition from initiation to elongation and that binding of 
TFB2M and TEFM to mtRNAP are mutually exclusive.
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Figure 7 |. Model for transcription initiation in human mitochondria.
The TFAM binding site and the transcription start site (TSS) are indicated. TFAM (red) 
binding bends the DNA upstream of the TSS and leads to recruitment of mtRNAP (gray) to 
form the closed pre-initiation complex. Binding of TFB2M (blue) leads to melting of the 
DNA duplex and the bending of the downstream DNA observed in the open initiation 
complex. Promoter escape and transition to the elongation complex involve repositioning of 
the upstream DNA duplex (dashed arrow) and binding of TEFM (raspberry), which occupies 
a similar site on mtRNAP as TFB2M in the IC.
Hillen et al. Page 27
Cell. Author manuscript; available in PMC 2019 June 24.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
See also Movie S1.
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